Advanced Search
Current and Breaking News for Professionals, Consumers and Media


Click here to learn how to advertise on this site and for ad rates.

Research Author: Nick Hanson Last Updated: Jul 10, 2008 - 8:13:19 AM



Drug Curbs Gambling Urge
By Nick Hanson
Jul 10, 2008 - 8:07:34 AM

Email this article
 Printer friendly page
Used in combination with therapy, naltrexone--an alcoholism drug--offers hope for pathological gamblers

University psychiatrist Jon Grant found that a common alcoholism drug has an effect on the urge to gamble.

(HealthNewsDigest.com) - It appears that a drug--naltrexone--commonly used to treat alcohol addiction has other applications. One of them is curbing pathological gambling.

In a recent University of Minnesota study, naltrexone helped a group of addicts significantly drop their gambling intensity and frequency. The results were published in a recent issue of the Journal of Clinical Psychiatry.

"This is good news for people who have a gambling problem," says Jon Grant, a University of Minnesota associate professor of psychiatry and principal investigator of the study. "This is the first time people have a proven medication that can help them get their behavior under control."

While the drug is not a cure for gambling, Grant says it offers hope to many who are suffering from addiction. He also says the drug would most likely work best in combination with individual therapy.

Forty percent of the 49 participants who took the drug and completed the study, quit gambling for at least one month.
"Medication can be helpful, but people with gambling addiction often have multiple other issues that should be addressed through therapy," he says. He estimates between 1 to 3 percent of the population has a gambling problem.

Grant is an addiction expert who has published more than 150 studies on topics like gambling, shoplifting, drugs, and sex. His studies focus on therapies, treatments, and brain imaging to better understand addiction and eventually alleviate it.

"We're trying to understand the mechanisms that underlie these compulsive behaviors and treat them," Grant says. "Ideally, we would like to prevent them."

About the study

Seventy-seven people participated in the double-blind (meaning neither researchers nor participants know who belongs to the control and the experimental groups), placebo controlled study. Their ages ranged from 18 to 75 and they reported gambling for 6 to 32 hours each week.

Fifty-eight men and women took 50, 100, or 150 milligrams of naltrexone every day for 18 weeks. Forty percent of the 49 participants who took the drug and completed the study quit gambling for at least one month. Their urge to gamble also significantly dropped in intensity and frequency.

The other 19 participants took a placebo. But, only 10.5 percent of those were able to abstain from gambling.

Dosage did not have an impact on the results, naltrexone was generally well tolerated, and men and women reported similar results.

Naltrexone is sold under the brand names Revia and Depade. An extended-release formulation is sold under the name Vivitrol.

www.HealthNewsDigest.com

Top of Page

HealthNewsDigest.com

Research
Latest Headlines


+ Misreading of Damaged DNA May Spur Tumor Formation
+ Yale’s Reed Honored for Outstanding Nanotechnology Research
+ Adverse Effects of Street Drug 'Ecstasy'
+ Pfizer Launches Global Regenerative Medicine Research Unit
+ Novel IBS Treatment Developed at UB Garners $8.5 Million for Seven-Year Clinical Trial
+ $3.9 Million Grant Pumps Up Heart Monitoring Study at Yale School of Nursing
+ Protein Can Nurture or Devastate Brain Cells
+ Stem Cells from Monkey Teeth Can Stimulate Growth and Generation of Brain Cells
+ Battling Bacteria in the Blood
+ Large Study Identifies New Genetic Risk Factors for Brain Aneurysm



Contact Us | Job Listings | Help | Site Map | About Us
Advertising Information | HND Press Release | Submit Information | Disclaimer

Site hosted by Sanchez Productions